Opexa Therapeutics Inc (NASDAQ:OPXA)

1.57
Data as of 2:02pm ET
 -0.05 / -3.09%
Today’s Change
1.07
Today|||52-Week Range
5.19
+38.01%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$13.1M

Company Description

Opexa Therapeutics, Inc. is a biopharmaceutical company developing personalized cellular therapies with the potential to treat major illnesses, including multiple sclerosis. These therapies are based on its proprietary T-cell technology. The Tovaxin is a personalized T-cell vaccine for the treatment of multiple sclerosis that is specifically tailored to each patient's disease profile. The company was founded on 2004 and is headquartered in The Woodlands, TX.

Contact Information

Opexa Therapeutics, Inc.
2635 Technology Forest Boulevard
The Woodlands Texas 77381
P:(281) 775-0600
Investor Relations:

Employees

Shareholders

Individual stakeholders6.59%
Other institutional4.53%
Mutual fund holders1.27%

Top Executives

Neil K. Warma, MBAPresident, Chief Executive Officer & Director
Donna R. RillSenior Vice President-Operations & Quality Systems
Karthik Radhakrishnan, CFA, MBAChief Financial Officer
Kenny S. FrazierVP-Clinical Development & Regulatory Affairs
Donald Healey, PhDVice President-Scientific Development

To view my watchlist

Not a member yet?

Sign up now for a free account

jobs by SimplyHired

Search for jobs

Search All Jobs from Across the Web

Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2013 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2013 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2013. All rights reserved. Most stock quote data provided by BATS.